K

L

Lumira Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

9

Common Fundraising Type

Series B

C
Cardiac Dimensions

Minimally invasive • Cardiovascular

Ally Bridge Group logo
Lumira Ventures logo
Hostplus logo
Horizon 3 Healthcare logo

Cardiac Dimensions develops and commercializes the Carillon Mitral Contour System, a minimally invasive device for treating functional mitral regurgitation in heart failure patients.

Series E
$53M
03/21/2025
Article
S
Sound Blade Medical

Medical device • Ultrasound-guided

Amzak Health logo
Lumira Ventures logo
Invest Nova Scotia logo

Sound Blade Medical develops innovative handheld ultrasound-guided histotripsy technology for non-invasive tissue ablation.

Series A
$16.5M
01/29/2025
Article
X
XyloCor Therapeutics

Gene therapy • Cardiovascular diseases

Jeito Capital logo
Lumira Ventures logo
Fountain Healthcare Partners logo
EQT logo

XyloCor Therapeutics develops gene therapies for cardiovascular diseases, focusing on treatments for refractory angina and coronary artery bypass graft surgery.

Series B
$67.5M
01/07/2025
Article
A
Axonis Therapeutics

Biotechnology • Neuromedicines

venBio Partners logo
Sofinnova Investments logo
Solasta Ventures logo
SCI Ventures logo

Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

Series A
$115M
10/30/2024
Article
A
Alpha-9 Oncology

Radiopharmaceuticals • Clinical-stage

Ascenta Capital logo
Lightspeed Venture Partners logo
Samsara BioCapital logo
RA Capital Management logo

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Series C
$175M
10/23/2024
Article
S
SpectraWAVE

Medical imaging • Coronary stenting

SV Health Investors logo
S3 Ventures logo
NovaVenture logo
Johnson & Johnson Innovation - JJDC logo

SpectraWAVE, Inc. develops advanced medical imaging systems to improve coronary stenting procedures and enhance clinical decision-making in the treatment of coronary artery disease.

Series B
$50M
09/11/2024
Article
H
HistoSonics

Medical device • Non-invasive

Alpha Wave Ventures logo
Yonjin Venture logo
Venture Investors logo
Wisconsin Investment Board logo

HistoSonics is a medical device company that develops non-invasive histotripsy platforms, including the Edison® Histotripsy System, to mechanically destroy and liquefy targeted liver tumors using focused ultrasound.

Series D
$102M
08/15/2024
Article
S
Specific Biologics

Biotechnology • Gene Editing

adMare BioInnovations logo
Lumira Ventures logo

Specific Biologics is a biotechnology company focused on developing therapeutics for genetic diseases using its proprietary Dualase® platform gene editors.

Equity
Undisclosed
10/16/2023
Article
D
Deka Biosciences

Biotech • Immunotherapy

MPM BioImpact logo
Viva BioInnovator logo
Plains Ventures logo
Lumira Ventures logo

Deka Biosciences is a biotech company that aims to improve immunotherapy treatments by combining biology with precision medicine, specifically through their investigational new drug, DK210 (EGFR), which has dissociated IL-2 potency from toxicity.

Series B
$20M
09/28/2023
Article